Patent directory · USPTO A61K / A61P
Patents matching “COR Therapeutics, Inc.”
30 pharma patents match "COR Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 30 pharmaceutical patents matching "COR Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9623085
Chimeric natriuretic peptide compositions and methods of preparation
granted -
US 9616107
Therapy for kidney disease and/or heart failure
granted -
US 9314507
Methods of treatment of heart failure with natriuretic peptides
granted -
US 6399627
Inhibitors of factor Xa
expired -
US 6376515
Benzamides and related inhibitors of factor Xa
expired -
US 6369080
Selective factor Xa inhibitors
expired -
US 6369063
Selective factor Xa inhibitors
expired -
US 6333321
Selective factor Xa inhibitors
expired -
US 6297026
Nucleic acids encoding the C140 receptor
expired -
US 6291469
Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
expired -
US 6262047
Selective factor Xa inhibitors
expired -
US 6245743
Inhibitors of factor Xa
expired -
US 6228854
Selective factor Xa inhibitors
expired -
US 6218382
Selective factor Xa inhibitors
expired -
US 6210913
Modulation of integrin-mediated signal transduction
expired -
US 6211183
Selective factor Xa inhibitors
expired -
US 6211154
Ketoheterocyclic inhibitors of factor Xa
expired -
US 6204268
Selective factor Xa inhibitors
expired -
US 6197748
Ketoheterocyclic inhibitors of factor Xa
expired -
US 6194557
Nucleic acid molecules encoding Bap-1 proteins
expired -
US 6133256
Selective factor Xa inhibitors
expired -
US 6117836
Glycosylation-mediated inhibition of factor X
expired -
US 6083688
Platelet glycoprotein V gene and uses
expired -
US 6069130
Ketoheterocyclic inhibitors of factor Xa
expired